No adverse effects were reported and a significant reduction in liver tests (specifically transaminases and gamma-glutamyltranspeptidase -GGT-), with many cases of bio humoral parameters normalization, was detected in all treated patients, even several months after treatment interruption
Patients should: Keep the skin clean and moisturized Avoid applying lotions or creams immediately before injecting Use gentle, fragrance-free skincare products Temperature management Managing the temperature of both the medication and the injection site can help reduce discomfort and reactions: Allow refrigerated tirzepatide to come to room temperature before injecting Consider using a cold pack on the injection site before and after administration to reduce inflammation Monitoring and reporting Patients should closely monitor their injection sites and report any unusual reactions to their healthcare provider
Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution
23, Novo Nordisk released late-stage study results showing participants who took its next-generation obesity drug, CagriSema, didn't lose as much weight as those who took rival Eli Lilly's Zepbound
The enhanced absorption and immediate availability of nutrients make IV therapy a superior option for many patients seeking to improve their health and well-being
Interestingly, it has been found that bronchoalveolar lavage fluid (fluid used to wash the lungs) contains higher concentrations of GLP-1 than blood, indicating that GLP-1 plays an important role in the lungs (5)
